Agilent provides xCELLigence impedance-based, label-free, real time cell analysis system and NovoCyte flow cytometers.
Automated microscopy and image analysis
Real-time, label free cell analysis
Nano and micro particle analysis
Accelerate to discover
Back to filter
Show all topics (10)
Related topics
Cytek webinar : Evaluating Spectral Cytometry for Immune Profiling in Viral Disease
Apr 19, 2021
In conventional fluorescence cytometry, each fluorophore in a panel is measured in a target detector, through the use...
Rethinking 3D cell culture with IncuCyte: advanced cell cultures from iPSCs and organoids
Apr 14, 2021
The world is neither flat nor two-dimensional, so why should cell culture be? Traditional cell culture systems grow...
The impact of environmental Oxygen content on Natural Killer Cell Immunotherapy
Apr 13, 2021
Natural Killer (NK) cells are being studied in the clinic in a number of settings, including solid tumor...
Mar 31, 2021
Cancer cells exhibit metabolic...
Cytek webinar recording : Improved flow cytometry assay resolution with autofluorescence extraction
Mar 30, 2021
The power of autofluorescence extraction in the detection of dim fluorescence on highly autofluorescent cells, and the...
Unleash Your Illumina Sequencer with TELL-Seq Linked Reads
Mar 24, 2021
Sage Science distributes universal sequencing technology´s TELL-Seq linked-read NGS library prep kits used with very...
Bruker webinar : High-resolution exploration of ESM-based vascularized tissue-flaps
Mar 22, 2021
By employing a tissue engineering approach based on biological tissue constructs, Dr. Redenski has fabricated composite...
A real time-saver, accurate cell counting in 15 seconds with C100 counter
Mar 17, 2021
Cell counters are tools for counting live and/or dead cells in a culture. Any researcher who works in a cell culture...
Differentation displacement in acute myeloid leukemia through enhancer activation
Aug 7, 2018
LSD1 is a flavin adenine dinucleotide (FAD)-dependent homolog of the amine oxidase family and there was recently brought attention to it as a potential therapeutic target. The interest came from an observation of unusually high expression of LSD1 in certain types of poor-prognosis cancers. It was previously thought that LSD1 removes monomethyl and dymethyl histone marks. However, recently it was showed that it interacts with multiple transcripton factor. This raised a possibility of other drugs being used.
New inhibitor ORY-1001 was succesfully tested on LSD1 and blast cell differentioation was observed. The flow cytometric testing on this experiment was done with Novocyte. ORY-1001 disrupts the protein interaction between LSD1 and GFI1.
Related technologies: Conventional flow cytometry
Get more info
Brand profile
